Company / Operating Cash Flow per Share
Gossamer Bio, Inc. Operating Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.76
FY2025
5-year range
-$2.52 / -$0.02
FY2021-FY2025
Trend
-4812.4%
vs FY2024
Sector context
#107 of 212
Health Care
What the data says
Operating Cash Flow per Share changed -4812% YoY in FY2025, a notable deviation from the 8-year average annual change of -716%.
Based on SEC 10-K filings.
-0.76 in FY2025.
Improved from $-1.04 to $-0.76 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#107 of 212 in Health CareTop 50% of 212This company -$0.76 Sector average -$14.72
▼
+94.9% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 4812.4% year-over-year.
- Ranks #107 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.76 | -4812.4% |
| FY2024 | -$0.02 | +98.5% |
| FY2023 | -$1.04 | +52.8% |
| FY2022 | -$2.21 | +12.4% |
| FY2021 | -$2.52 | +2.0% |
| FY2020 | -$2.57 | +2.7% |
| FY2019 | -$2.65 | +66.3% |
| FY2018 | -$7.85 | -1151.3% |
| FY2017 | -$0.63 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026